PT  - JOURNAL ARTICLE
AU  - Chesney, Jason
AU  - Lewis, Karl D
AU  - Kluger, Harriet
AU  - Hamid, Omid
AU  - Whitman, Eric
AU  - Thomas, Sajeve
AU  - Wermke, Martin
AU  - Cusnir, Mike
AU  - Domingo-Musibay, Evidio
AU  - Phan, Giao Q
AU  - Kirkwood, John M
AU  - Hassel, Jessica C
AU  - Orloff, Marlana
AU  - Larkin, James
AU  - Weber, Jeffrey
AU  - Furness, Andrew J S
AU  - Khushalani, Nikhil I
AU  - Medina, Theresa
AU  - Egger, Michael E
AU  - Graf Finckenstein, Friedrich
AU  - Jagasia, Madan
AU  - Hari, Parameswaran
AU  - Sulur, Giri
AU  - Shi, Wen
AU  - Wu, Xiao
AU  - Sarnaik, Amod
TI  - Efficacy and safety of lifileucel, a one-time autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in patients with advanced melanoma after progression on immune checkpoint inhibitors and targeted therapies: pooled analysis of consecutive cohorts of the C-144-01 study
AID  - 10.1136/jitc-2022-005755
DP  - 2022 Dec 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e005755
VI  - 10
IP  - 12
4099  - http://jitc.bmj.com/content/10/12/e005755.short
4100  - http://jitc.bmj.com/content/10/12/e005755.full
SO  - J Immunother Cancer2022 Dec 01; 10
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.